Clinical trial
Role of Gene Variation in Effectiveness of Gleevec Treatment
NCT00342056 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00342056 |
|---|---|
| Title | Role of Gene Variation in Effectiveness of Gleevec Treatment |
| Official title | Analysis of ABCG2 Genotype in Gleevec Treated Cancer Patients to Assess the Association of a Single Nucleotide Polymorphism (C421A) in ABCG2 and Response to Treatment |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cancer, Breast Cancer |
| Enrollment | 100 |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2008 |
| First posted | Jun 21, 2006 |
| Last update posted | May 25, 2011 |
| Countries | Belgium, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: